Cold‐stored platelets are effective in an in vitro model of massive transfusion protocol assessed by rotational thromboelastometry. (24th June 2022)

• Record Type: Journal Article
• Authors: Zhao, Han Qi; Serrano, Katherine; Culibrk, Brankica; Chen, Zhongming; Devine, Dana V.
• Other Names: Yazer Mark H. guestEditor.; Watts Sarah A. guestEditor.; Woolley Col Tom guestEditor.
• Is Part Of: Transfusion. Volume 62(2022)Supplement 1
• Page Start: S53
• Page End: S62
• Publication Date: 2022-06-24
• Subjects: cold‐stored platelets -- storage -- transfusion -- trauma; Hematology -- Periodicals; Blood -- Transfusion -- Periodicals; Blood Group Antigens -- Periodicals; Blood Preservation -- Periodicals; Blood Transfusion -- Periodicals; 615
• DOI: 10.1111/trf.16974
• Languages: English
• ISSNs: 0041-1132

Abstract

Abstract: Background: Platelets are a key component of massive transfusion in treating actively bleeding patients. While optimized for prophylactic transfusions, the effectiveness of the current standard room temperature stored platelets (RPs) in treating actively bleeding patients is not clear. Cold‐stored platelets (CPs) have been shown to have superior hemostatic functions and the potential to extend shelf life. In this study, we explored the effect of using CPs versus RPs in an in vitro transfusion model based on the massive transfusion protocol. Study Design and Methods: RPs or CPs were combined with RBCs and plasma in a 1:1:1 volume ratio to make transfusion packages. Whole blood was collected and then either diluted to 20% hematocrit or mixed with tPA (8.8 μg/ml). By volume, 70% of transfusion package was mixed with 30% whole blood to simulate massive transfusions and analyzed by rotational thromboelastometry. Transfusion package supernatant was analyzed for PAI‐1 activity as well. Results: Both transfusion packages restored the clot characteristics of hemodiluted or hyperfibrinolytic whole blood. Specifically, only transfusion packages made with CPs significantly reduced the maximum clot lysis of hyperfibrinolytic whole blood. PAI‐1 activity in CPs transfusion packages were also significantly higher. Discussion: Transfusion packages containing cold‐stored platelets may be able to restore the blood hemostatic profile of bleeding patients. In addition, transfusion packages made from CPs may provide additional benefit of resisting hyperfibrinolysis in bleeding patients. In trauma where post‐transfusion platelet recovery is less of a concern, CPs are a viable option to restore hemostasis.